Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OneTouch Ultra Shipment Stoppage Unlikely To Impact J&J/LifeScan Sales

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson/LifeScan's decision to temporarily cease shipments of its OneTouch Ultra, OneTouch FastTake and InDuo blood glucose meters likely will not significantly affect the unit's revenue, the firm said

You may also be interested in...



FDA Warning Letter Cites J&J Unit For Not Heeding “User Error” Complaints

Johnson & Johnson/LifeScan received a warning letter for neglecting to adequately follow up on frequent reports of user errors associated with its blood glucose meters

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.

UsernamePublicRestriction

Register

MT021995

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel